Nuveen Asset Management, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 168 filers reported holding NOVOCURE LTD in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$5,307,859
-56.9%
328,660
+10.7%
0.00%
-50.0%
Q2 2023$12,315,788
+67849.2%
296,766
-1.5%
0.00%
-42.9%
Q1 2023$18,125
-18.1%
301,382
-0.1%
0.01%
-22.2%
Q4 2022$22,134
-99.9%
301,757
-17.1%
0.01%
-18.2%
Q3 2022$27,658,000
+12.5%
364,016
+2.9%
0.01%
+10.0%
Q2 2022$24,589,000
-13.1%
353,792
-1.8%
0.01%
+11.1%
Q1 2022$28,304,000
+4.5%
360,425
-0.1%
0.01%
+12.5%
Q4 2021$27,083,000
-41.8%
360,721
-10.0%
0.01%
-42.9%
Q3 2021$46,541,000
-57.3%
400,628
-18.4%
0.01%
-56.2%
Q2 2021$108,876,000
+75.0%
490,831
+4.3%
0.03%
+60.0%
Q1 2021$62,229,000
-26.3%
470,788
-3.5%
0.02%
-31.0%
Q4 2020$84,453,000
+113.8%
488,057
+37.5%
0.03%
+93.3%
Q3 2020$39,504,000
+169.9%
354,908
+43.8%
0.02%
+150.0%
Q2 2020$14,638,000
-61.6%
246,835
-56.4%
0.01%
-68.4%
Q1 2020$38,083,000
-5.5%
565,539
+18.3%
0.02%
+26.7%
Q4 2019$40,299,000
+11.1%
478,211
-1.4%
0.02%0.0%
Q3 2019$36,268,000
+17.3%
484,996
-4.6%
0.02%
+25.0%
Q2 2019$30,922,000
+2545.2%
508,172
+1994.7%
0.01%
+100.0%
Q1 2019$1,169,000
-85.6%
24,260
-90.0%
0.01%
-88.2%
Q4 2018$8,093,000
-62.8%
241,728
-41.7%
0.05%
-55.7%
Q3 2018$21,741,000
+59.1%
414,910
-5.0%
0.12%
+33.7%
Q2 2018$13,668,000
+110.1%
436,685
+46.3%
0.09%
+104.8%
Q1 2018$6,506,000298,4280.04%
Other shareholders
NOVOCURE LTD shareholders Q4 2018
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders